Revolutionary Blood Screening Test Demonstrates Potential to Identify Dozens of Cancer Types Sooner
A groundbreaking blood test has demonstrated remarkable success in detecting over 50 cancer types in major clinical trials. The test identified more than half of cancers at early stages when they’re most treatable, according to study results presented at a leading medical conference.
Major Cancer Detection Breakthrough
A revolutionary blood test designed to detect more than 50 types of cancer has delivered highly promising results in one of the largest interventional screening trials conducted to date, according to reports presented at the European Society for Medical Oncology Congress 2025 in Berlin. The PATHFINDER 2 study of the Galleri multi-cancer early detection (MCED) test reportedly showed a more than seven-fold increase in cancer detection rates when used alongside standard recommended screenings.